Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

              Author:Hershey, Andrew D.   Szperka, Christina L.   Barbanti, Piero   Pozo-Rosich, Patricia   Bittigau, Petra   Barash, Steve   Garnett, Sally   Bryson, Juline   Kessler, Yoel   Carmeli Schwartz, Yael   Ning, Xiaoping   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Headache  

              Program Number:PL5.001  

              Author Institution:Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Headache and Pain Unit, IRCCS San Raffaele, Rome, Italy, and San Raffaele University, Rome, Italy, Rome, Italy  Headache Unit and Research Group, Vall d’Hebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain, Barcelona, Spain  Charité-Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel, Tel Aviv, Israel  

              Towards a Standardized Process of Onboarding Advanced Practice Providers into Headache Medicine Practices in the United States

              Author:Freeman, Marshall   Cook, Calli   Ailani, Jessica   Ehrlich, Annika   Grosberg, Brian   Samaha, Marielle   Moriarty, Maureen   Secora, Karissa   VanderPluym, Juliana   Birlea, Laur Marius   

              Session Name:P1: Headache: Population Health and Outcomes Research  

              Topic:Headache  

              Program Number:P1.009  

              Author Institution:Headache Wellness Center, Greensboro, NC  Emory Healthcare, Atlanta, GA  Medstar Georgetown Neurology, McLean, VA  UCSF Headache Center, San Francisco, CA  Hartford HealthCare Headache Center, West Hartford, CT  Cincinnati Children's Hosp Medl Ctr, Cincinnati, OH  Moriarty Associates, Westminster, MD  Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Scottsdale, AZ  University of Colorado, Aurora, CO  

              Effectiveness of Treatments used in New Daily Persistent Headache in Children & Adolescents

              Author:Abu-Halaweh, Nassim   Gelfand, Amy   Evans, Morgan   Marquez de Prado, Blanca   Patterson Gentile, Carlyn   Raj, Nichelle   Hershey, Andrew   Szperka, Christina   

              Session Name:P5: Headache: Clinically Oriented Research 1  

              Topic:Headache  

              Program Number:P5.001  

              Author Institution:University of Pennsylvania Perelman School of Medicine, Philadelphia, PA  University of California San Francisco, San Francisco, CA  Children's Hospital of Philadelphia, Philadelphia, PA  Cincinnati Children's Hospital, Montgomery, OH  Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA  

              Treatment of Status Epilepticus At and After T1 With Diazepam Nasal Spray: A Combined Cohort Analysis

              Author:Segal, Eric   Stern, John   Becker, Danielle   Jarrar, Randa   Glauser, Tracy   Peters, Jurriaan   Shih, Evelyn   Carrazana, Enrique   Rabinowicz, Adrian   

              Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P8.013  

              Author Institution:Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA  Ohio State University Wexner Medical Center, Columbus, OH  Phoenix Children’s Hospital, Phoenix, AZ  Comprehensive Epilepsy Center, Cincinnati Children’s Hospital, Cincinnati, OH  

              Miglustat: A First-In-Class Enzyme Stabilizer for Late-Onset Pompe Disease

              Author:Mozaffar, Tahseen   Byrne, Barry J.   Dimachkie, Mazen   Hopkin, Robert J.   Kishnani, Priya   Roberts, Mark   Schoser, Benedikt   Van Der Ploeg, Ans   Brudvig, Jon   Fox, Brian   Holdbrook, Frederick   Jain, Vipul   Johnson, Franklin   Zhang, Jennifer   Parenti, Giancarlo   

              Session Name:P10: General Neurology: New, Potential, and Innovative Treatments 2  

              Topic:General Neurology  

              Program Number:P10.012  

              Author Institution:University of California, Irvine, Irvine, CA  University of Florida, Gainesville, Gainesville, FL  University of Kansas Medical Center, Kansas City, KS  Cincinnati Children's Hospital Medical Center, Cincinnati, OH  Duke University Medical Center, Durham, NC  Salford Royal NHS Foundation Trust, Salford, United Kingdom  LMU University Hospital, LMU Munich, Munich, Germany  Erasmus MC University Medical Center, Rotterdam, Netherlands  Amicus Therapeutics, Inc., Princeton, NJ  University of Naples Federico II, Naples, Italy